Flagship Harbor Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-140
Closed -$3K 1939
2018
Q4
$3K Hold
140
﹤0.01% 1580
2018
Q3
$5K Sell
140
-285
-67% -$10.8K ﹤0.01% 1706
2018
Q2
$15K Buy
+425
New +$15.4K ﹤0.01% 1222

Other funds holding SBIO

Flagship Harbor Advisors's SBIO Position: Q1 2019 in Review

Flagship Harbor Advisors sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q1 2019, closing a stake of 140 shares — an estimated $3K sold.

Flagship Harbor Advisors first reported a position in SBIO in Q2 2018 and held it in 3 quarters. The position peaked at $15K in Q2 2018. 47 funds tracked by Wall St. Rank hold SBIO as of Q1 2019.

  • Flagship Harbor Advisors reported no remaining ALPS Medical Breakthroughs ETF position as of Q1 2019 after selling out during the quarter.
  • Flagship Harbor Advisors sold 140 ALPS Medical Breakthroughs ETF shares in Q1 2019, an estimated $3K.
  • Flagship Harbor Advisors first reported a position in ALPS Medical Breakthroughs ETF in Q2 2018 and held it in 3 quarters.
  • Flagship Harbor Advisors's ALPS Medical Breakthroughs ETF position peaked at $15K in Q2 2018.
  • 47 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2019.

Based on Flagship Harbor Advisors's 13F filing for Q1 2019, filed 15 Apr 2019.